1/28
Looks like no tags are added yet.
In general, can nanoparticles permeate cell membranes better than a small lipophilic molecule in solution?
No.
Yes.
Yes.
B and C.
Size above the glomerular filtration cutoff of ~4 nm, and a hydrophilic surface.
Cell surface proteins/features that allow cell entry, and dose amplification due to replication in the host.
Endotoxins released can alter barriers and increase permeability; bacterial dose amplifies in the host due to replication.
Higher permeability across leaky tumor vasculature relative to normal (tight) vasculature, and reduced removal from the tumor site due to lower lymphatic clearance.
Decreases (ARPE-19 uptake was highest for 20 nm particles and lowest for 1000-2000 nm).
Microparticles: lower surface/volume ratio and less surface area exposed to biological fluids.
Nanoparticle, since cell entry is low for the hydrophilic macromolecules used in gene therapy.
Nanoparticles (lipid nanoparticles; Comirnaty and Spikevax).
Microparticles. Settling velocity rises steeply with size (100 nm = 4.3 nm/s; 1,000 nm = 430 nm/s; 10,000 nm = 43,005 nm/s). A 100 nm particle takes ~2.69 days to settle 1 mm, so nanoparticles stay suspended.
Nanoparticles, due to more Brownian (random) movement.
Microparticle (more prolonged release; the drug is well permeable so it does not need nanoparticle-enhanced entry).
No solvent toxicity (no need for corticosteroid and antihistamine premedication); 30 min vs 3 hr infusion; 1.5x dose tolerated; 2x better response rate. Abraxane = paclitaxel bound to albumin (130 nm), approved January 2005.
Pure drug particles; composite particles of drug + carrier (lipids, proteins, polymers, etc.); particle size stabilizers may be included.
Yes. Eye drops have short residence time, so sticky particles adhere better to the ocular surface, and rapid entry limits removal by blinking. Nanoparticles also enhance cell uptake of poorly permeable drugs.
BONUS: Nanoparticle settling velocity vs size
1 nm = 0.00043 nm/s; 10 nm = 0.043; 100 nm = 4.30; 1,000 nm = 430; 10,000 nm = 43,005. A 100 nm particle takes 2.69 days to settle 1 mm (superior ability to remain suspended).
BONUS: Brownian displacement in 1 second vs size
1 nm = 54,250 nm; 10 nm = 17,155; 100 nm = 5,425; 1,000 nm = 1,716; 10,000 nm = 543. Nanoparticles are highly mobile, so interactions with cells are highly likely.
BONUS: Percent surface molecules vs particle size (1 nm low MW drug)
1 nm = 100%; 10 nm = 27.1%; 100 nm = 2.97%; 1,000 nm = 0.30%; 10,000 nm = 0.03%. Smaller particles have more surface exposure, so faster release.
BONUS: Benefits of nanotechnology for drug and gene delivery
Enhanced permeation and retention; enhanced cell uptake (poorly permeable drugs); targeting to cells and organelles; prolonged suspension; stimuli-sensitive drug release; sustained delivery is feasible, but larger systems might provide more prolonged release.
BONUS: Selection criteria for a nano delivery system
Disease, drug, route, NP disposition, safety, and IP. All nanosystems (albumin, chitosan, PAMAM dendrimer, PLGA, PEG-coated liposome) can be functionalized.
BONUS: Recently approved nanomedicines
Onpattro (patisiran, siRNA in lipid NP; hATTR polyneuropathy; 2018). Comirnaty (mRNA for SARS-CoV-2 spike in lipid NP; COVID-19 prevention; 2021). Spikevax (same type; 2022).
BONUS: Sticky/rapid uptake NP in the eye
Used in eye drops. Short residence time of drops means sticky particles adhere better to the ocular surface; rapid entry limits removal by blinking.
BONUS: Stealth/targeting NP for IV dosing in retinal vascular leakage
Small NP reach the retina via leaky vascular regions. Stealth is imparted by coating with inert polymers like PEG, which diminishes uptake by circulating cells.
BONUS: Stealth/slow release/diffusible NP in the vitreous
Stealth minimizes clearance from the eye; slow release limits frequent intravitreal injections (avoids endophthalmitis); diffusible NP are needed to reach retinal tissue beyond the vitreous.
BONUS: Shock/sono/photo responsive NP for the eye
NPs made of materials responsive to electrical input, ultrasound, or light, so these stimuli can control drug release at the target site.